Clinical Trial Update: NT-I7 for Kaposi Sarcoma in Patients With or Without HIV [Phase 1]

View source ↗

Summary

A Phase 1 trial of NT-I7 for AIDS-related Kaposi sarcoma in patients with or without HIV was terminated; results were posted on 2024-06-27.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Kaposi Sarcoma

Drugs mentioned

• NT-I7

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: AIDS-Related Kaposi Sarcoma, HIV Infection | Phase 1 | Status: TERMINATED | Results posted: 2024-06-27